Asish Dasgupta

2.0k total citations
27 papers, 1.4k citations indexed

About

Asish Dasgupta is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Asish Dasgupta has authored 27 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Molecular Biology, 13 papers in Pulmonary and Respiratory Medicine and 4 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Asish Dasgupta's work include Mitochondrial Function and Pathology (16 papers), Pulmonary Hypertension Research and Treatments (13 papers) and ATP Synthase and ATPases Research (11 papers). Asish Dasgupta is often cited by papers focused on Mitochondrial Function and Pathology (16 papers), Pulmonary Hypertension Research and Treatments (13 papers) and ATP Synthase and ATPases Research (11 papers). Asish Dasgupta collaborates with scholars based in Canada, United States and India. Asish Dasgupta's co-authors include Stephen L. Archer, Kuang‐Hueih Chen, Danchen Wu, Jeffrey Mewburn, Lian Tian, François Potus, Kimberly J. Dunham‐Snary, Sébastien Bonnet, Jessica Huston and John Ryan and has published in prestigious journals such as Circulation, The Journal of Immunology and Circulation Research.

In The Last Decade

Asish Dasgupta

27 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Asish Dasgupta Canada 20 966 565 279 242 163 27 1.4k
Fernando de la Cuesta Spain 25 899 0.9× 144 0.3× 369 1.3× 280 1.2× 220 1.3× 67 1.6k
Hui Lin China 22 642 0.7× 121 0.2× 405 1.5× 179 0.7× 154 0.9× 73 1.4k
Yun‐Song Lee South Korea 16 444 0.5× 295 0.5× 85 0.3× 108 0.4× 64 0.4× 22 923
John C. Marecki United States 18 460 0.5× 356 0.6× 164 0.6× 65 0.3× 190 1.2× 30 1.5k
Daniel Hernández-Saavedra United States 17 331 0.3× 342 0.6× 146 0.5× 78 0.3× 107 0.7× 32 1.1k
Dean J. Kleinhenz United States 14 458 0.5× 272 0.5× 152 0.5× 68 0.3× 90 0.6× 15 1.0k
Xu Shi United States 18 624 0.6× 115 0.2× 172 0.6× 76 0.3× 112 0.7× 31 1.2k
Jehangir Mistry United States 20 686 0.7× 101 0.2× 249 0.9× 221 0.9× 286 1.8× 45 1.6k
Min Zheng China 21 723 0.7× 192 0.3× 73 0.3× 227 0.9× 137 0.8× 41 1.4k
Joshua K. Salabei United States 17 643 0.7× 81 0.1× 117 0.4× 180 0.7× 308 1.9× 36 1.2k

Countries citing papers authored by Asish Dasgupta

Since Specialization
Citations

This map shows the geographic impact of Asish Dasgupta's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Asish Dasgupta with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Asish Dasgupta more than expected).

Fields of papers citing papers by Asish Dasgupta

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Asish Dasgupta. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Asish Dasgupta. The network helps show where Asish Dasgupta may publish in the future.

Co-authorship network of co-authors of Asish Dasgupta

This figure shows the co-authorship network connecting the top 25 collaborators of Asish Dasgupta. A scholar is included among the top collaborators of Asish Dasgupta based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Asish Dasgupta. Asish Dasgupta is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wu, Danchen, et al.. (2023). Acquired disorders of mitochondrial metabolism and dynamics in pulmonary arterial hypertension. Frontiers in Cell and Developmental Biology. 11. 1105565–1105565. 21 indexed citations
2.
3.
Al‐Qazazi, Ruaa, Patrícia Lima, Sasha Z. Prisco, et al.. (2022). Macrophage–NLRP3 Activation Promotes Right Ventricle Failure in Pulmonary Arterial Hypertension. American Journal of Respiratory and Critical Care Medicine. 206(5). 608–624. 98 indexed citations
4.
Motamed, Mehras, Kuang‐Hueih Chen, Asish Dasgupta, et al.. (2022). Inhibiting pyruvate kinase muscle isoform 2 regresses group 2 pulmonary hypertension induced by supra‐coronary aortic banding. Acta Physiologica. 234(2). e13764–e13764. 7 indexed citations
5.
Wu, Danchen, Asish Dasgupta, Austin Read, et al.. (2021). Oxygen sensing, mitochondrial biology and experimental therapeutics for pulmonary hypertension and cancer. Free Radical Biology and Medicine. 170. 150–178. 49 indexed citations
6.
Dasgupta, Asish, Kuang‐Hueih Chen, Patricia D.A. Lima, et al.. (2021). PINK1‐induced phosphorylation of mitofusin 2 at serine 442 causes its proteasomal degradation and promotes cell proliferation in lung cancer and pulmonary arterial hypertension. The FASEB Journal. 35(8). e21771–e21771. 36 indexed citations
7.
Dasgupta, Asish, Danchen Wu, Lian Tian, et al.. (2020). Mitochondria in the Pulmonary Vasculature in Health and Disease: Oxygen‐Sensing, Metabolism, and Dynamics. Comprehensive physiology. 10(2). 713–765. 45 indexed citations
8.
Dasgupta, Asish, Danchen Wu, Lian Tian, et al.. (2020). Mitochondria in the Pulmonary Vasculature in Health and Disease: Oxygen‐Sensing, Metabolism, and Dynamics. Comprehensive physiology. 10(2). 713–765. 7 indexed citations
9.
Motamed, Mehras, Asish Dasgupta, Ashley Martin, et al.. (2020). Inhibiting Pyruvate Kinase Muscle Isoform 2 with Shikonin Regresses Supra-Coronary Aortic Banding Induced Group 2 Pulmonary Hypertension. A6073–A6073. 1 indexed citations
10.
Dasgupta, Asish, Kuang‐Hueih Chen, Danchen Wu, et al.. (2020). An epigenetic increase in mitochondrial fission by MiD49 and MiD51 regulates the cell cycle in cancer: Diagnostic and therapeutic implications. The FASEB Journal. 34(4). 5106–5127. 20 indexed citations
11.
Tian, Lian, Danchen Wu, Asish Dasgupta, et al.. (2020). Epigenetic Metabolic Reprogramming of Right Ventricular Fibroblasts in Pulmonary Arterial Hypertension. Circulation Research. 126(12). 1723–1745. 117 indexed citations
12.
Tian, Lian, Kimberly J. Dunham‐Snary, Kuang‐Hueih Chen, et al.. (2019). Biventricular Increases in Mitochondrial Fission Mediator (MiD51) and Proglycolytic Pyruvate Kinase (PKM2) Isoform in Experimental Group 2 Pulmonary Hypertension-Novel Mitochondrial Abnormalities. Frontiers in Cardiovascular Medicine. 5. 195–195. 26 indexed citations
13.
Tian, Lian, François Potus, Danchen Wu, et al.. (2018). Increased Drp1-Mediated Mitochondrial Fission Promotes Proliferation and Collagen Production by Right Ventricular Fibroblasts in Experimental Pulmonary Arterial Hypertension. Frontiers in Physiology. 9. 828–828. 67 indexed citations
14.
Chen, Kuang‐Hueih, Asish Dasgupta, Jian-Hui Lin, et al.. (2018). Epigenetic Dysregulation of the Dynamin-Related Protein 1 Binding Partners MiD49 and MiD51 Increases Mitotic Mitochondrial Fission and Promotes Pulmonary Arterial Hypertension. Circulation. 138(3). 287–304. 134 indexed citations
15.
Tian, Lian, Monica Neuber‐Hess, Jeffrey Mewburn, et al.. (2017). Ischemia-induced Drp1 and Fis1-mediated mitochondrial fission and right ventricular dysfunction in pulmonary hypertension. Journal of Molecular Medicine. 95(4). 381–393. 82 indexed citations
16.
Hong, Zhigang, Asish Dasgupta, François Potus, et al.. (2016). MicroRNA-138 and MicroRNA-25 Down-regulate Mitochondrial Calcium Uniporter, Causing the Pulmonary Arterial Hypertension Cancer Phenotype. American Journal of Respiratory and Critical Care Medicine. 195(4). 515–529. 136 indexed citations
17.
Ryan, John, et al.. (2015). Mitochondrial dynamics in pulmonary arterial hypertension. Journal of Molecular Medicine. 93(3). 229–242. 131 indexed citations
18.
Dasgupta, Asish. (2014). Possibilities of Developing New Formulations for Better Skin Protection from a Traditional Medicinal Plant Having Potent Practical Usage. British Journal of Pharmaceutical Research. 4(7). 870–879. 3 indexed citations
19.
Chen, Kuang‐Hueih, Asish Dasgupta, Jinhui Ding, et al.. (2013). Role of mitofusin 2 (Mfn2) in controlling cellular proliferation. The FASEB Journal. 28(1). 382–394. 93 indexed citations
20.
Dasgupta, Asish & Sujata G. Dastidar. (2012). Antibacterial & antitoxic effects of the cardiovascular drug lacidipine in an animal model.. PubMed. 135(6). 913–6. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Fernando de la Cuesta Breakdown of academic impact, for papers by Hui Lin Breakdown of academic impact, for papers by Yun‐Song Lee Breakdown of academic impact, for papers by John C. Marecki Breakdown of academic impact, for papers by Daniel Hernández-Saavedra Breakdown of academic impact, for papers by Dean J. Kleinhenz Breakdown of academic impact, for papers by Xu Shi Breakdown of academic impact, for papers by Jehangir Mistry Breakdown of academic impact, for papers by Min Zheng Breakdown of academic impact, for papers by Joshua K. Salabei
Rankless by CCL
2026